학술논문
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
Document Type
Article
Author
Source
In: American Journal of Hematology . (American Journal of Hematology, 1 December 2019, 94(12):1353-1363)
Subject
Language
English
ISSN
10968652
03618609
03618609